GENE ONLINE|News &
Opinion
Blog

Tumor Microenvironment
Latest Discovery in Metabolic Pathways of T-Cells Opens New Door to Immunology Research
2023-02-23
Jounce Sells Anti-CCR8 Antibody to Gilead, Forgoing $645 Million In Milestones
2022-12-28
Combining STING Agonists and pHLIPs to Enhance Cancer Treatments
2022-11-09
Parthenon Therapeutics Launches with $65 Million Series A to Advance Immuno-Oncology Treatment
2021-11-07
Day 1 ESMO 2021 Roundup: Investigational Immunotherapies Show Promise in Early Cancer Trials
2021-09-18
New IO Targets and Resistance Mechanisms of Immune Checkpoint-Based Therapies
2021-06-10
Day 4 ASCO 2021 Roundup: Immunotherapy Candidates Show Promise in Early Studies
2021-06-09
A Glance at Gene Therapy Advances in Cancer
2021-05-16
R&D
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
T Cells and Cancer: Uncovering the Unknowns
2021-04-16
Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System
2020-10-08
Gilead Adds Jounce to its Long List of Oncology Partnerships
2020-09-03
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
R&D
AACR 2020: Modifications in Tumor Microenvironment and Host Microbiome, a Potential Therapeutic Strategy for Immunotherapy
2020-05-08
1 2
LATEST
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
Discover the Next Billion-Dollar Unicorn at the Biotech Innovation Funding Networking Event
2024-03-21
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top